Cargando…

Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language Processing

INTRODUCTION: This study aimed to assess the feasibility of applying natural language processing (NLP) to analyze real-world data (RWD) and resolve clinical problems in patients with secondary hyperparathyroidism and chronic kidney disease undergoing hemodialysis (SHPT/CKD-HD). The primary objective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortiz, Alberto, Portoles, Jose, Pino-Pino, Maria Dolores, Barea, Jesús, López, María, de Sequera, Patricia, Quiroga, Borja, Echarri, Rocio, Prieto Velasco, Mario, Díaz, Rafael, Gómez Marqués, Gonzalo, Sanchez Perez, Pilar, Torregrosa, Vicens, Rodriguez, Mariano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368074/ https://www.ncbi.nlm.nih.gov/pubmed/37497203 http://dx.doi.org/10.1159/000528784

Ejemplares similares

Protocolo de actuación ante la epidemia de enfermedad por coronavirus en los pacientes de diálisis y trasplantados renales
por: de Sequera Ortiz, Patricia, et al.
Publicado: (2020)

Protocol against coronavirus diseases in patients on renal replacement therapy: Dialysis and kidney transplant()
por: de Sequera Ortiz, Patricia, et al.
Publicado: (2020)

Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum
por: Quiroga, Borja, et al.
Publicado: (2022)

Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum
por: Quiroga, Borja, et al.
Publicado: (2023)

Management of Kidney Failure in Patients with Diabetes Mellitus: What Are the Best Options?
por: Buades, Juan M., et al.
Publicado: (2021)

Suboptimal personal protective equipment and SARS-CoV-2 infection in Nephrologists: a Spanish national survey
por: Quiroga, Borja, et al.
Publicado: (2021)

Managing hyperparathyroidism in hemodialysis: role of etelcalcetide
por: Eidman, Keith E, et al.
Publicado: (2018)

Actualización de las recomendaciones de medidas de prevención y aislamiento frente al SARS-CoV-2 en las unidades de diálisis: un posicionamiento de la Sociedad Española de Nefrología
por: de Sequera, Patricia, et al.
Publicado: (2022)

Update of the prevention and isolation measure recommendations against SARS-COV-2 in dialysis units of Spain: A position paper of the Spanish Society of Nephrology Council
por: de Sequera, Patricia, et al.
Publicado: (2022)

SARS-CoV-2 Infection Evolution Among Nephrologists During the Pandemic: Clinical Features and Impact of Vaccination
por: Quiroga, Borja, et al.
Publicado: (2022)

Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
por: Hauber, Brett, et al.
Publicado: (2017)

Long-Term Dynamic Humoral Response to SARS-CoV-2 mRNA Vaccines in Patients on Peritoneal Dialysis
por: Quiroga, Borja, et al.
Publicado: (2022)

Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2020)

Posicionamiento de la Sociedad Española de Nefrología ante la vacunación frente al SARS-CoV-2
por: Sánchez-Álvarez, Emilio, et al.
Publicado: (2021)

Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines()
por: Sánchez-Álvarez, Emilio, et al.
Publicado: (2021)

Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
por: Shigematsu, Takashi, et al.
Publicado: (2018)

Correction to: From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes
por: Quiroga, Borja, et al.
Publicado: (2022)

From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes
por: Quiroga, Borja, et al.
Publicado: (2022)

Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis
por: Al-Hilali, N., et al.
Publicado: (2009)

Parathyroidectomy Is Associated with Reduced Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism
por: Ma, Tsung-Liang, et al.
Publicado: (2015)

PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2016)

Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Alvarado, Luis, et al.
Publicado: (2022)

Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits
por: Chen, Xiu, et al.
Publicado: (2021)

Impact of parathyroidectomy among nondiabetic hemodialysis patients with severe hyperparathyroidism
por: Huang, Qing-xiu, et al.
Publicado: (2022)

Severe hyperparathyroidism is associated with nutritional impairment in maintenance hemodialysis patients
por: Disthabanchong, Sinee, et al.
Publicado: (2022)

Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis
por: Diao, Zongli, et al.
Publicado: (2016)

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Cunningham, John, et al.
Publicado: (2019)

Fibrous dysplasia in maxilla in a patient on hemodialysis with severe secondary hyperparathyroidism
por: Yang, Hui-Hsin, et al.
Publicado: (2022)

Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics
por: Arenas, Maria Dolores, et al.
Publicado: (2020)

Impacto de la pandemia COVID-19 en los servicios de Nefrología españoles
por: Soler, María José, et al.
Publicado: (2020)

Impact of COVID-19 pandemic in Spanish Nephrology Servicesservices impact of the pandemic on COVID-19 Spanish Nephrology Services()
por: Soler, María José, et al.
Publicado: (2020)

The Association between Music and Language in Children: A State-of-the-Art Review
por: Pino, Maria Chiara, et al.
Publicado: (2023)

Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
por: Kuczera, Piotr, et al.
Publicado: (2016)

An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism
por: Block, Geoffrey A., et al.
Publicado: (2019)

Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”
por: Russo, Domenico, et al.
Publicado: (2019)

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
por: Bushinsky, David A, et al.
Publicado: (2019)

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
por: Bushinsky, David A, et al.
Publicado: (2019)

Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism
por: Tokumoto, Masanori, et al.
Publicado: (2022)

Observation of the efficacy of parathyroidectomy for secondary hyperparathyroidism in hemodialysis patients: a retrospective study
por: Qiu, Wenqiang, et al.
Publicado: (2023)

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination
por: Gonzalez-Perez, Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5m0295f32002cekl6g41l483uo